Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Patidegib
Therapeutic Area : Rare Diseases and Disorders
Study Phase : Phase III
Recipient : PellePharm
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : PellePharm’s patedigib topical gel is an investigational treatment to be used for rare dermatologic conditions. This is the first step in efforts to enable the renewable production of cyclopamine.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 01, 2021
Lead Product(s) : Patidegib
Therapeutic Area : Rare Diseases and Disorders
Highest Development Status : Phase III
Recipient : PellePharm
Deal Size : Inapplicable
Deal Type : Inapplicable
KEY PRODUCTS
Reset All
Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.
